Advertisement

Probiotics: The Ultimate Nutritional Supplement

  • Rout George Kerry
  • Pratima Pradhan
  • Dibyaranjan Samal
  • Sushanto Gouda
  • Gitishree Das
  • Han-Seung Shin
  • Jayanta Kumar Patra
Chapter

Abstract

Microorganism live inside the human body and thus the human are inimitable reservoir for diverse and vibrant group of microbes. These microbial species primarily modulates the host internal environment for the edification in the host health. This spectacular symbiotic relationship is under extensive research in recent years. The significance of these organisms in various metabolic activities inside the body is very crucial. Therefore any alterations in their diversity may results in several fatal diseases and disorders. The efficacy of the classical therapy is consecutively demising with the emergence of tolerance as well as resistance to these therapeutic drugs. Henceforth, a simple, cheaper, receptive and intrinsic means for health benefactor is a vital compulsion of the present era which could be achieved by the means of probiotics. Research have proved that probiotics supplementation against various enteric pathogens has shown promising results with their exceptional ability to compete with pathogenic microbes for various purposes by initiating the activation of specific genes of localized host cells. In the current chapter, the beneficial effect of probiotics consumption in human health and medical sectors has been discussed.

Keywords

Probiotics Microbiota Biotechnology Pathogens Supplement 

References

  1. Akelma AZ, Topcu ZIK (2016) Probiotics and allergic disease. World J Immunol 6I:75–82CrossRefGoogle Scholar
  2. Ammor S, Tauveron G, Dufour E, Chevallier I (2006) Antibacterial activity of lactic acid bacteria against spoilage and pathogenic bacteria isolated from the same meat small-scale facility: screening and characterization of the antibacterial compounds. Food Control 17:454–461CrossRefGoogle Scholar
  3. Bakirtzi K, Law IKM, Xue X et al (2016) Neurotensin promotes the development of colitis and intestinal angiogenesis via Hif-1α–miR-210 signaling. J Immunol 196:4311–4321CrossRefGoogle Scholar
  4. Barrett HL, Callaway LK, Nitert MD (2012) Probiotics: a potential role in the prevention of gestational diabetes? Acta Diabetol 49:1–13CrossRefGoogle Scholar
  5. Barz ML, Anhe FF, Varin TV (2015) Probiotics as complementary treatment for metabolic disorders. Diabetes Metab J 39:291–303CrossRefGoogle Scholar
  6. Bongaerts GPA, Severijnen RSVM (2016) A reassessment of the PROPATRIA study and its implications for probiotic therapy. Nat Biotechnol 34:55–63CrossRefGoogle Scholar
  7. Cammarota G, Ianiro G, Cianci R et al (2015) The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacol Ther 149:191–212CrossRefGoogle Scholar
  8. Cammarota G, Pecere S, Ianiro G et al (2016) Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases. Dig Dis 34:279–285CrossRefGoogle Scholar
  9. Chan PA, Robinette A, Montgomery M et al (2016) Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol 5758387:17Google Scholar
  10. Chen X, Yang G, Song J-H et al (2013) Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. PLoS One 8:1–7CrossRefGoogle Scholar
  11. Curro D, Ianiro G, Pecere S et al (2016) Probiotics, fiber and herbal medicinal products for functional and inflammatory bowel disorders. Brit J Pharmacol 173:61–68Google Scholar
  12. Figueroa-Gonzalez I, Cruz-Guerrero A, Quijano G (2011) The benefits of probiotics on human health. J Microb Biochem Technol S1:003Google Scholar
  13. Fuller R (1989) Probiotics in man and animals. J Appl Bacteriol 66:365–378CrossRefGoogle Scholar
  14. Gayathri D, Rashmi BS (2016) Anti-cancer properties of probiotics: a natural strategy for cancer prevention. EC Nutr 5:1191–1202Google Scholar
  15. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonie microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412PubMedPubMedCentralGoogle Scholar
  16. Gowri RS, Meenambigai P, Prabhavathi P et al (2016) Probiotics and its effects on human health-a review. Int J Curr Microbiol Appl Sci 5:384–392CrossRefGoogle Scholar
  17. Hamasalim HJ (2016) Synbiotic as feed additives relating to animal health and performance. Adv Microbiol 6:288–302CrossRefGoogle Scholar
  18. Hanson L, Vusse LV, Jerme M et al (2016) Probiotics for treatment and prevention of urogenital infections in women: a systematic review. J Midwifery Womens Health 61:339–355CrossRefGoogle Scholar
  19. Hartstra AV, Bouter KEC, Backhed F, Nieuwdorp M (2015) Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 38:159–165CrossRefGoogle Scholar
  20. Hu C, Wong FS, Wen L (2015) Type 1 diabetes and gut microbiota: friend or foe? Pharmacol Res 98:9–15CrossRefGoogle Scholar
  21. Iqbal MZ, Qadir MI, Hussain T et al (2014) Probiotics and their beneficial effects against various diseases. Pak J Pharm Sci 27:405–415PubMedGoogle Scholar
  22. Islam SU (2016) Clinical uses of probiotics. Medicine 95:1–5CrossRefGoogle Scholar
  23. Kahouli I, Malhotra M, Alaoui-Jamali MA, Prakash S (2015) In-vitro characterization of the anti-cancer activity of the probiotic bacterium Lactobacillus fermentum NCIMB 5221 and potential against colorectal cancer cells. J Cancer Sci Ther 7:224–235Google Scholar
  24. Kang J-H, Yun S-I, Park M-H et al (2013) Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One 8:1–8CrossRefGoogle Scholar
  25. Kareem KY, Ling FH, Chwen LT et al (2014) Inhibitory activity of postbiotic produced by strains of Lactobacillus plantarum using reconstituted media supplemented with inulin. Gut Pathog 6:1–7CrossRefGoogle Scholar
  26. Karimi G, Sabran MR, Jamaluddin R et al (2015) The anti-obesity effects of Lactobacillus casei strain shirota versus orlistat on high fat diet-induced obese rats. Food Nutr Res 59:1–8CrossRefGoogle Scholar
  27. Kobyliak N, Conte C, Cammarota G et al (2016) Probiotics in prevention and treatment of obesity: a critical view. Nutr Metab 13:1–13CrossRefGoogle Scholar
  28. Kristensen NB, Bryrup T, Allin KH et al (2016) Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med 8:1–11CrossRefGoogle Scholar
  29. Larsen N, Vogensen FK, vanden Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5:1–10Google Scholar
  30. Lewis BB, Buffie CG, Carter R et al (2015) Loss of microbiota-mediated colonization resistance to Clostridium difficile infection is greater following oral vancomycin as compared with metronidazole. J Infect Dis 212:1656–1665CrossRefGoogle Scholar
  31. Lilly DM, Stillwell RH (1965) Growth promoting factors produced by probiotics. Science 147:747–748CrossRefGoogle Scholar
  32. Ljungberg M, Korpela R, Ilonen J et al (2006) Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type-1 diabetes-the PRODIA study. Ann N Y Acad Sci 1079:360–364CrossRefGoogle Scholar
  33. Mayer EA, Tillisch K, Gupta A (2015) Gut/brain axis and the microbiota. J Clin Invest 125:926–938CrossRefGoogle Scholar
  34. Messaoudi M, Lalonde R, Violle N et al (2010) Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 105:755–764CrossRefGoogle Scholar
  35. Metchnikoff E, Mitchell PC (1907) Essais optimistes. Heinemann, LondonGoogle Scholar
  36. Ooi MF, Mazlan N, Foo HL et al (2015) Effects of carbon and nitrogen sources on bacteriocin-inhibitory activity of postbiotic metabolites produced by Lactobacillus plantarum I-UL4. Malays J Microbiol 11:176–184Google Scholar
  37. Palumbo VD, Marcello R, Gammazza AM et al (2016) The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study. Biomed Pap 160:372–377CrossRefGoogle Scholar
  38. Patel RM, Denning PW (2013) Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence? Clin Perinatol 40:11–25CrossRefGoogle Scholar
  39. Perez-Cobas AE, Moya A, Gosalbes MJ, Latorre A (2015) Colonization resistance of the gut microbiota against Clostridium difficile. Antibiotics 4:337–357CrossRefGoogle Scholar
  40. Rao AV, Bested AC, Beaulne TM et al (2009) A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 1:1–6CrossRefGoogle Scholar
  41. Rao SC, Athalye-Jape GK, Deshpande GC et al (2016) Probiotic supplementation and late-onset sepsis in preterm infants: a meta-analysis. Pediatrics 137:1–16CrossRefGoogle Scholar
  42. Shahverdi E (2016) Probiotics and gastrointestinal diseases. Int J Dig Dis 2:1–2Google Scholar
  43. Simova ED, Beshkova DB, Dimitrov P (2009) Characterization and antimicrobial spectrum of bacteriocins produced by lactic acid bacteria isolated from traditional Bulgarian dairy products. J Appl Microbiol 106:692–701CrossRefGoogle Scholar
  44. Song S, Lee SJ, Park D-J et al (2016) The anti-allergic activity of Lactobacillus plantarum L67 and its application to yogurt. J Dairy Res 99:9372–9382CrossRefGoogle Scholar
  45. Spiller R (2016) Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Research 5:1–11CrossRefGoogle Scholar
  46. Takeda S, Hidaka M, Yoshida H et al (2016) Antiallergic activity of probiotics from Mongolian dairy products on type I allergy in mice and mode of antiallergic action. J Funct Foods 9:60–69CrossRefGoogle Scholar
  47. Tejero-Sarinena S, Barlow J, Costabile A et al (2013) Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains? Anaerobe 24:60–65CrossRefGoogle Scholar
  48. Tillisch K (2014) The effects of gut microbiota on CNS function in humans. Gut Microbes 5:404–410CrossRefGoogle Scholar
  49. Tissier H (1906) Tritement des infections intestinales par la methode de translormation de la flore bacterienne de lintestin. C R Soc Biol 60:359–361 (in French)Google Scholar
  50. Umbrello G, Esposito S (2016) Microbiota and neurologic diseases: potential effects of probiotics. J Transl Med 14:1–11CrossRefGoogle Scholar
  51. Vafaeie F (2016) Critical review on probiotics and its effect on cancer. Cancer Press 2:30–34CrossRefGoogle Scholar
  52. Vidya S, Thiruneelakandan G (2015) Probiotic potentials of lactobacillus and its anti-cancer activity. Int J Curr Res 7:20680–20684Google Scholar
  53. Waigankar SS, Patel V (2011) Role of probiotics in urogenital healthcare. J Midlife Health 2:5–10PubMedPubMedCentralGoogle Scholar
  54. World Health Organization (2017) Cancer fact sheet 2017. World Health Organization, GenevaGoogle Scholar
  55. Yoo J, Kim S (2016) Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Forum Nutr 8:1–20Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Rout George Kerry
    • 1
  • Pratima Pradhan
    • 1
  • Dibyaranjan Samal
    • 2
  • Sushanto Gouda
    • 3
  • Gitishree Das
    • 4
  • Han-Seung Shin
    • 5
  • Jayanta Kumar Patra
    • 4
  1. 1.P.G. Department of BiotechnologyAcademy of Management and Information TechnologyKhurdaIndia
  2. 2.Guruji Foods and BeveragesHSIIDC BarhiSonipatIndia
  3. 3.Amity Institute of Wildlife ScienceAmity UniversityNoidaIndia
  4. 4.Research Institute of Biotechnology and Medical Converged ScienceDongguk UniversityGoyang-siSouth Korea
  5. 5.Department of Food Science and BiotechnologyDongguk UniversityGoyangSouth Korea

Personalised recommendations